Researchers at the University of Minnesota have developed YCT-529, a non-hormonal male birth control pill showing efficacy in ...

Soleno Therapeutics stock has surged over 1,500% since September 2023, driven by the progress and today's FDA approval of ...

The high-stakes nature of cancer care, coupled with rapid scientific advancements, increasing payer and regulatory pressures, ...

Lumenis Be. Ltd., a leading energy-based medical device company, is proud to announce the expansion of FoLixtm, the first and only FDA-cleared fractional laser for hair loss, to Canada. Following its ...

OPKO Health, Inc. OPK is well-poised for growth in the coming quarters, courtesy of its potential in RAYALDEE. The optimism ...

Are we truly on the brink of a cure for obesity? Or could neglecting the root causes risk worsening the very problems we seek ...

For decades, birth control options for men have been limited to just two choices: condoms or a vasectomy. Meanwhile, women have more than 20 types of approved contraceptives, including the widely used ...

PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, is pleased to ...

Vykat XR will be available in April to treat the intense hunger that is a hallmark of the rare genetic disease Prader-Willi ...

FY 2024 net product revenues increased 140% to $607.6 thousand.FY 2024 gross profit increased $443.8 thousand from ($221 thousand) to $222.8 ...

Cancer refers to a group of complicated diseases which is one of the top two leading causes of death globally. Traditional chemotherapy and radiation ...